tiprankstipranks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
Holding LEXX?
Track your performance easily

Lexaria Bioscience (LEXX) Financial Statements

188 Followers

Lexaria Bioscience Financial Overview

Lexaria Bioscience's market cap is currently ―. The company's EPS TTM is $-0.457; its P/E ratio is -4.88; Lexaria Bioscience is scheduled to report earnings on April 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24May 24Feb 24Nov 23Aug 23
Income Statement-
Total Revenue$ 84.00K$ 84.00K$ 145.00K$ 151.28K$ -104.91K
Gross Profit$ 84.00K$ 84.00K$ 145.00K$ 146.46K$ -104.91K
EBIT$ -2.19M$ -1.78M$ -652.73K$ -1.19M$ -1.35M
EBITDA$ -2.17M$ -1.77M$ -636.80K$ -1.16M$ -1.28M
Net Income Common Stockholders$ -2.18M$ -1.78M$ -652.73K$ -1.18M$ -1.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.56M$ 8.51M$ 4.79M$ 2.03M$ 1.48M
Total Assets$ 8.87M$ 10.02M$ 6.35M$ 3.63M$ 3.08M
Total Debt$ 137.37K$ 142.59K$ 148.88K$ 155.07K$ 163.97K
Net Debt$ -6.42M$ -8.36M$ -4.64M$ -1.87M$ -1.31M
Total Liabilities$ 1.21M$ 271.38K$ 204.20K$ 254.04K$ 403.91K
Stockholders Equity$ 8.04M$ 10.12M$ 6.52M$ 3.74M$ 3.04M
Cash Flow-
Free Cash Flow--$ -676.60K$ -1.22M$ -1.69M
Operating Cash Flow$ -1.89M$ -1.27M$ -619.61K$ -1.18M$ -1.62M
Investing Cash Flow$ -69.59K$ -22.00K$ -56.99K$ -40.03K$ -68.44K
Financing Cash Flow-$ 5.04M$ 3.45M$ 1.82M$ -121.69K
Currency in USD

Lexaria Bioscience Earnings and Revenue History

Lexaria Bioscience Debt to Assets

Lexaria Bioscience Cash Flow

Lexaria Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis